Duration of dual antiplatelet therapy in patients with CKD and drug-eluting stents: a meta-analysis
- Mavrakanas, Thomas A
- Chatzizisis, Yiannis S
- Gariani, Karim
- Kereiakes, Dean J
- Gargiulo, Giuseppe
- Helft, Gérard
- Gilard, Martine
- Feres, Fausto
- Costa, Ricardo A
- Morice, Marie-Claude
- Georges, Jean-Louis
- Valgimigli, Marco
- Bhatt, Deepak L
- Mauri, Laura
- Charytan, David M
DOIAbstract
Whether prolonged dual antiplatelet therapy (DAPT) is more protective in patients with CKD and drug-eluting stents compared with shorter DAPT is uncertain. The purpose of this meta-analysis was to examine whether shorter DAPT in patients with drug-eluting stents and CKD is associated with lower mortality or major adverse cardiovascular event rates compared with longer DAPT
Add to ORKG